Skip to content

Home
What Is Breast Cancer?
Treatment
Columns
COVID-19 Info
- COVID-19 Updates

Search for:

allergic reactions

January 5, 2017

10 Possible Allergic Reactions to Breast Cancer Treatments

Going through breast cancer treatment is difficult. The treatment can make you sick, tired and to top it all off, you can even suffer an allergic reaction to your medication ... Read more

August 17, 2016

5 Mild Allergic Reactions to Breast Cancer Treatment

There are several treatment options to address breast cancer, depending on the severity of the cancer. But with some treatments, side-effects and reactions come that can affect some patients. Since ... Read more

Search for:

Recent Posts

Enhertu Approved in UK for Inoperable, Advanced Breast Cancer

February 22, 2021
Phase 2 Trial Will Test IRX-2 Combined With Keytruda, Chemotherapy for TNBC

February 18, 2021
Tukysa Combo Approved in EU for Advanced HER2-Positive Breast Cancer

February 15, 2021

Featured Post

FDA’s New ‘Project Patient Voice’ to Share Symptoms Data From Cancer Trials

June 30, 2020

Visit Breast Cancer News's profile on Pinterest.

FDA Approves Phesgo as Injection Treatment for HER2-positive Breast Cancers

July 1, 2020

FDA Approves Tukysa for Advanced HER2-positive Breast Cancer

May 7, 2020

Bionews, Inc.

3 W Garden St
Suite 700
Pensacola, FL 32502
Email: info@Bionews.com
Phone: +1-800-936-1363

Publishing Team
Leadership
Our Values
Terms of Service
Privacy Policy
Corrections Policy
Contact Us

Disclaimer:

Breast Cancer News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright © 2013-2025 All rights reserved.

We use cookies to enhance your experience on our website. Privacy PolicyAccept